Focus On Abbott Labs Remains On Pending Deals

By: via Benzinga
Qualifying the second quarter results of Abbott Laboratories (NYSE: ABT) as solid, UBS indicated the focus of investors is now on the ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.